Select for export Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2023.05.16.540994 Copy citation Copy BibTeX bioRxiv 2023-05-17 Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG bioRxiv PREPRINT (not peer reviewed) psilocybinpsilocin DepressionAnxietyPharmacology Clinical Trial More
Select for export Exposure therapy under psilocybin for general anxiety disorder and claustrophobia Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-2859973/v1 Copy citation Copy BibTeX Research Square 2023-05-11 THORENS G, PENZENSTADLER l, FURTADO LCDC, SERAGNOLI F, ROTHEN S, MABILAIS C Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionAnxietyCase Report Case Report More
Select for export Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2023.05.11.540409 Copy citation Copy BibTeX bioRxiv 2023-05-11 Singleton SP, Timmermann C, Luppi AI, Eckernäs E, Roseman L, Carhart-Harris RL bioRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingPharmacologyReceptor Pharmacology Other More
Select for export Unblinding and demand characteristics in the treatment of depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2023.02.030 PubMed 36781142 Copy citation Copy BibTeX Journal of affective disorders 2023-04-30 Goodwin GM, Croal M, Marwood L, Malievskaia E PubMed Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Randomized Controlled Trial More
Select for export A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2023.04.12.23288325 Copy citation Copy BibTeX medRxiv 2023-04-18 Bennett JN, Blough MD, Mitchell I, Galloway L, Bains R. medRxiv PREPRINT (not peer reviewed) psilocybin Mystical ExperienceClinical TrialSafety Clinical Trial More
Select for export 509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural Activity No abstract availability was recorded for this entry. Details DOI 10.1016/j.biopsych.2023.02.749 Copy citation Copy BibTeX Biological Psychiatry 2023-04-09 Jonah H. Shepherd, Caitlin Baten, Amanda M. Klassen, Gladys Zamora, Sarah Saravia, Elizabeth Pritchard OpenAlex Published psilocybin Brain ImagingReceptor PharmacologyAging Meta-Analysis More
Select for export 118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment? No abstract availability was recorded for this entry. Details DOI 10.1016/j.biopsych.2023.02.358 Copy citation Copy BibTeX Biological Psychiatry 2023-04-09 Aron Amaev, Jianmeng Song, Yasaman Kambari, Fumihiko Ueno, Edgardo Torres-Carmona, Ali Abdolizadeh OpenAlex Published psilocybin NeuroplasticityReceptor Pharmacology Other More
Select for export The Theoretical Description for Psilocin Electrochemical Determination over Cobalt Oxyhydroxide Abstract available at the source but not redistributed here. Read at source. Details DOI 10.17807/orbital.v15i1.18012 Copy citation Copy BibTeX Orbital: The Electronic Journal of Chemistry 2023-04-05 Volodymyr Tkach, Kucher Mykhailo, Kushnir Marta, Ivanushko Yana, Akınay Yüksel, Karakoyun Necdet Crossref Published psilocin General Other More
Select for export Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment No abstract availability was recorded for this entry. Details DOI 10.1016/j.mehy.2023.111068 Copy citation Copy BibTeX Medical Hypotheses 2023-04-04 Jianmeng Song, Yasaman Kambari, Aron Amaev, Fumihiko Ueno, Edgardo Torres Carmona, Vincenzo De Luca OpenAlex Published psilocybin NeuroplasticityReceptor Pharmacology Other More
Select for export Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder No abstract availability was recorded for this entry. Details DOI 10.1016/j.jpsychires.2023.03.031 PubMed 37004409 Copy citation Copy BibTeX Journal of Psychiatric Research 2023-03-27 Franklin R. Schneier, Jamie D. Feusner, Michael G. Wheaton, Gloria J. Gomez, Giselle Cornejo, Akansha M. Naraindas OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects. No abstract availability was recorded for this entry. Details DOI 10.1176/appi.ajp.20220835 PubMed 36945824 Copy citation Copy BibTeX Unknown journal 2023-03-21 Rosenblat JD, Leon-Carlyle M, Ali S, Husain MI, McIntyre RS. Europe PMC Published psilocybin Depression Other More
Select for export Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1123424 PubMed 36998623 Copy citation Copy BibTeX Unknown journal 2023-03-13 Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR Europe PMC Published psilocybin AddictionClinical TrialReview Article Clinical Trial More
Select for export Interaction of psychedelic tryptamine derivatives with a lipid bilayer. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.chemphyslip.2023.105279 PubMed 36627076 Copy citation Copy BibTeX Chemistry and physics of lipids 2023-02-28 Zohairi F, Khandelia H, Hakami Zanjani AA PubMed Published psilocin DepressionAnxietyAddiction Other More
Select for export Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2023.1021729 PubMed 36874002 Copy citation Copy BibTeX Frontiers in Pharmacology 2023-02-15 Yahong Chen, Junhong Liu, Yishan Yao, Haitao Yan, Ruibin Su OpenAlex Published psilocin PharmacologyMechanism of ActionReceptor Pharmacology Animal Study More
Select for export The therapeutic potential of psychedelics: the European regulatory perspective No abstract availability was recorded for this entry. Details DOI 10.1016/s0140-6736(23)00264-7 PubMed 36780909 Copy citation Copy BibTeX The Lancet 2023-02-10 Florence Butlen-Ducuing, Drummond E-Wen McCulloch, Marion Haberkamp, Taina Mattila, Ewa Bałkowiec-Iskra, Georgios Aislaitner OpenAlex Published psilocybin Addiction Other More
Select for export Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2023.01.108 PubMed 36740140 Copy citation Copy BibTeX Journal of Affective Disorders 2023-02-02 Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James Bennett, Megan Croal OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health Abstract available at the source but not redistributed here. Read at source. Details DOI 10.9734/air/2023/v24i1931 Copy citation Copy BibTeX Advances in Research 2023-01-29 Jennings Hernandez OpenAlex Published psilocybin DepressionAnxietyPTSD Observational Study More
Select for export Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.59783/aire.2023.15 Copy citation Copy BibTeX AIDASCO Reviews 2023-01-16 Dragana Marković, Eleonora Čapelja OpenAlex Published psilocybinpsilocin DepressionAnxietyPTSD Other More
Select for export The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.102906 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons OpenAlex Published psilocybin DepressionObservational StudyTreatment-Resistant Depression Observational Study More
Select for export Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice No abstract availability was recorded for this entry. Details DOI 10.1016/j.nsa.2023.103378 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Sofia Nasini, Martina Colognesi, Sara Tidei, Sara De Martin, Marco Banzato, Andrea Mattarei OpenAlex Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
